Tuder RM, Archer SL, Dorfmüller P, Erzurum SC, Guignabert C, Michelakis E, Rabinovitch M, Schermuly R, Stenmark KR, Morrell NW. Relevant issues in the pathology and pathobiology of pulmonary hypertension. J Am College of Cardiol. 2013;62:D4–12.

Article  Google Scholar 

Shimoda LA, Laurie SS. Vascular remodeling in pulmonary hypertension. J Mol Med. 2013;91:297–309.

CAS  Article  Google Scholar 

Jeffery TK, Wanstall JC. Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension. Pharmacol Ther. 2001;92:1–20.

CAS  Article  Google Scholar 

Wang A, Valdez-Jasso D. Cellular mechanosignaling in pulmonary arterial hypertension. Biophys Rev. 2021;13:747–56.

Article  Google Scholar 

Vaillancourt M, Ruffenach G, Meloche J, Bonnet S. Adaptation and remodelling of the pulmonary circulation in pulmonary hypertension. Can J Cardiol. 2015;31:407–15.

Article  Google Scholar 

Humbert M, Guignabert C, Bonnet S, Dorfmüller P, Klinger JR, Nicolls MR, Olschewski AJ, Pullamsetti SS, Schermuly RT, Stenmark KR. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. Eur Respir J. 2019;53(1):1801887.

CAS  Article  Google Scholar 

Schaap FG, Rensen PC, Voshol PJ, Vrins C, van der Vliet HN, Chamuleau RA, Havekes LM, Groen AK, van Dijk KW. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis. J Biol Chem. 2004;279:27941–7.

CAS  Article  Google Scholar 

Zheng X-Y, Zhao S-P, Yu B-L, Wu C-L, Liu L. Apolipoprotein A5 internalized by human adipocytes modulates cellular triglyceride content. Biol Chem. 2012;393:161–7.

CAS  Article  Google Scholar 

Forte TM, Ryan RO. Apolipoprotein A5: extracellular and intracellular roles in triglyceride metabolism. Curr Drug Targets. 2015;16:1274–80.

CAS  Article  Google Scholar 

Luo J, Xu L, Li J, Zhao S. Effects and mechanisms of apolipoprotein AV on the regulation of lipid accumulation in cardiomyocytes. Lipids Health Dis. 2018;17:1–13.

Article  Google Scholar 

Brittain EL, Talati M, Fessel JP, Zhu H, Penner N, Calcutt MW, West JD, Funke M, Lewis GD, Gerszten RE, et al. Fatty acid metabolic defects and right ventricular lipotoxicity in human pulmonary arterial hypertension. Circulation. 2016;133:1936–44.

CAS  Article  Google Scholar 

Chen J, Luo J, Yang X, et al. Expression of ApoA5 and its function in the right ventricular failing and remodeling secondary to pulmonary hypertension[J]. J Cell Physiol. 2021;236(2):1013–24.

CAS  Article  Google Scholar 

Lin Y-C, Nunez V, Johns R, Shiao SPK. APOA5 gene polymorphisms and cardiovascular diseases: metaprediction in global populations. Nurs Res. 2017;66:164–74.

Article  Google Scholar 

Tao YC, Wang ML, Wu DB, Luo C, Tang H, Chen EQ. Apolipoprotein A5 alleviates LPS/D-GalN-induced fulminant liver failure in mice by inhibiting TLR4-mediated NF-kappaB pathway. J Transl Med. 2019;17:151.

Article  Google Scholar 

Wang C, Cui Y, Miao H, Xiong X, Dou J, Shao L, Tang X, Zhang Y. Apolipoprotein A-V Is a Novel Diagnostic and Prognostic Predictor in Pediatric Patients with Sepsis: A Prospective Pilot Study in PICU. Mediators Inflamm. 2020;2020:8052954.

PubMed  PubMed Central  Google Scholar 

Houssaini A, Abid S, Mouraret N, Wan F, Rideau D, Saker M, Marcos E, Tissot C-M, Dubois-Randé J-L, Amsellem V. Rapamycin reverses pulmonary artery smooth muscle cell proliferation in pulmonary hypertension. Am J Respir Cell Mol Biol. 2013;48:568–77.

CAS  Article  Google Scholar 

Zhao Y, Lv W, Piao H, Chu X, Wang H. Role of platelet-derived growth factor-BB (PDGF-BB) in human pulmonary artery smooth muscle cell proliferation. J Recept Signal Transduct Res. 2014;34:254–60.

CAS  Article  Google Scholar 

Mandegar M. Fung Y-CB, Huang W, Remillard CV, Rubin LJ, Yuan JX-J: cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension. Microvasc Res. 2004;68:75–103.

CAS  Article  Google Scholar 

Crnkovic S, Egemnazarov B, Damico R, Marsh LM, Nagy BM, Douschan P, Atsina K, Kolb TM, Mathai SC, Hooper JE. Disconnect between fibrotic response and right ventricular dysfunction. Am J Respir Crit Care Med. 2019;199:1550–60.

CAS  Article  Google Scholar 

Voelkel NF, Quaife RA, Leinwand LA, Barst RJ, McGoon MD, Meldrum DR, Dupuis J, Long CS, Rubin LJ, Smart FW. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation. 2006;114:1883–91.

Article  Google Scholar 

Schröder M, Kaufman RJ. ER stress and the unfolded protein response. Mutat Res. 2005;569:29–63.

Article  Google Scholar 

Hetz C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol. 2012;13:89–102.

CAS  Article  Google Scholar 

Hetz C, Papa FR. The unfolded protein response and cell fate control. Mol Cell. 2018;69:169–81.

CAS  Article  Google Scholar 

Lopez-Crisosto C, Pennanen C, Vasquez-Trincado C, Morales PE, Bravo-Sagua R, Quest AF, Chiong M, Lavandero S. Sarcoplasmic reticulum–mitochondria communication in cardiovascular pathophysiology. Nat Rev Cardiol. 2017;14:342–60.

CAS  Article  Google Scholar 

Wang J-J, Zuo X-R, Xu J, Zhou J-Y, Kong H, Zeng X-N, Xie W-P, Cao Q. Evaluation and treatment of endoplasmic reticulum (ER) stress in right ventricular dysfunction during monocrotaline-induced rat pulmonary arterial hypertension. Cardiovasc Drugs Ther. 2016;30:587–98.

CAS  Article  Google Scholar 

Cao X, He Y, Li X, Xu Y, Liu X. The IRE1α-XBP1 pathway function in hypoxia-induced pulmonary vascular remodeling, is upregulated by quercetin, inhibits apoptosis and partially reverses the effect of quercetin in PASMCs. Am J Transl Res. 2019;11:641.

CAS  PubMed  PubMed Central  Google Scholar 

Wu Y, Adi D, Long M, Wang J, Liu F, Gai M-T, Aierken A, Li M-Y, Li Q, Wu L-Q. 4-Phenylbutyric acid induces protection against pulmonary arterial hypertension in rats. PLoS One. 2016;11:e0157538.

Article  Google Scholar 

Dromparis P, Paulin R, Stenson TH, Haromy A, Sutendra G, Michelakis ED. Attenuating endoplasmic reticulum stress as a novel therapeutic strategy in pulmonary hypertension. Circulation. 2013;127:115–25.

CAS  Article  Google Scholar 

Guardiola M, Ribalta J. Update on APOA5 genetics: toward a better understanding of its physiological impact. Curr Atheroscler Rep. 2017;19:30.

Article  Google Scholar 

Sano R, Reed JC. ER stress-induced cell death mechanisms. Biochim Biophys Acta. 2013;1833:3460–70.

CAS  Article  Google Scholar 

Wilson DW, Segall H, Pan L, Lame M, Estep J, Morin D. Mechanisms and pathology of monocrotaline pulmonary toxicity. Crit Rev Toxicol. 1992;22:307–25.

CAS  Article  Google Scholar 

van der Vliet HN, Sammels MG, Leegwater AC, Levels JH, Reitsma PH, Boers W, Chamuleau RA. Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration. J Biol Chem. 2001;276:44512–20.

Article  Google Scholar